Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Est. Listeners
Based on iTunes & Spotify (publisher stats).
- Per-Episode Audience
Est. listeners per new episode within ~30 days
25,001 - 50,000 - Monthly Reach
Unique listeners across all episodes (30 days)
75,001 - 150,000 - Active Followers
Loyal subscribers who consistently listen
15,001 - 40,000
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
Challenges and Opportunities in the Diagnostic Pathway for Biliary Atresia
May 1, 2026
Unknown duration
Diabetic Macular Edema: Express Q&A on What's New
Apr 30, 2026
Unknown duration
The Science of SGLT1 and SGLT2: Unpacking Dual Inhibition for Heart Failure
Apr 13, 2026
Unknown duration
Liver Fibrosis in Type 2 Diabetes and Obesity: A Case-Based Approach
Mar 30, 2026
Unknown duration
Clinical Perspectives on the Use of PI3K/AKT Pathway Inhibitors in the Management of HR+/HER2− Metastatic Breast Cancer
Mar 23, 2026
Unknown duration
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 5/1/26 |  Challenges and Opportunities in the Diagnostic Pathway for Biliary Atresia | Recognize biliary atresia (BA) signs early to stop pediatric liver transplant. Gain expert insights on screening, diagnosis, and urgent referral pathways. Credit available for this activity expires: 05/01/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/challenges-and-opportunities-diagnostic-pathway-biliary-2026a1000bpb?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 4/30/26 | Diabetic Macular Edema: Express Q&A on What's New | Improve real-world DME outcomes by mastering the interpretation of evolving biomarkers and the latest evidence on long-acting anti-VEGF therapies. Credit available for this activity expires: [04/28/27] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/diabetic-macular-edema-express-q-whats-new-2026a1000czk?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 4/13/26 | The Science of SGLT1 and SGLT2: Unpacking Dual Inhibition for Heart Failure | Sodium-glucose cotransporter 2 (SGLT2) inhibitors transformed HF care. Meet SGLT1, a transporter that may unlock even greater CV protection. Credit available for this activity expires: 4/10/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/science-sglt1-and-sglt2-unpacking-dual-inhibition-heart-2026a1000axj?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 3/30/26 | Liver Fibrosis in Type 2 Diabetes and Obesity: A Case-Based Approach | Intervening early can stop metabolic dysfunction-associated steatohepatitis (MASH) progressing to fibrosis. Which of your patients with type 2 diabetes (T2D) or obesity need treatment, and what therapies are available? Credit available for this activity expires: 3/26/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/liver-fibrosis-type-2-diabetes-and-obesity-case-based-2026a10008y0?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 3/23/26 | Clinical Perspectives on the Use of PI3K/AKT Pathway Inhibitors in the Management of HR+/HER2− Metastatic Breast Cancer | Where do PI3K/AKT pathway inhibitors fit in the modern treatment landscape of breast cancer? Credit available for this activity expires: 3/19/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/clinical-perspectives-use-pi3k-akt-pathway-inhibitors-2026a100087h?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 3/18/26 | New Horizons in Uveitic Macular Edema | Do you know when to suspect edema in uveitis and how to manage it? Credit available for this activity expires: 3/18/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/new-horizons-uveitic-macular-edema-2026a10007ij?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 3/18/26 | Metabolic Crossroads: Navigating the Obesity–Liver Disease Axis | Do you know how to optimally identify, risk stratify, and treat your patients with obesity and MASLD or MASH? Credit available for this activity expires: 03/17/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/metabolic-crossroads-navigating-obesity-liver-disease-axis-2026a10007kf?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 3/11/26 | Beyond the Update in Advanced/Recurrent Endometrial Cancer: How Evidence Is Shaping New Guidelines | What clinical trials led to updates in the treatment strategies for advanced/recurrent endometrial cancer? Credit available for this activity expires: 3/9/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/beyond-update-advanced-recurrent-endometrial-cancer-how-2026a10006up?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 3/10/26 | Beyond PSMA: Preparing Your Practice for the Next Wave of Prostate Cancer Biomarkers | Are you up to speed on emerging biomarkers? Join our expert panel to learn more about their clinical relevance and testing best practices Credit available for this activity expires: 3/6/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/beyond-psma-preparing-your-practice-next-wave-prostate-2026a10006ql?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 3/5/26 | Avoiding Common Mistakes in Managing Focal Epilepsy | Do you know how many seizures is too many? Or what drugs to avoid in older epilepsy patients? Credit available for this activity expires: 3/3/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/avoiding-common-mistakes-managing-focal-epilepsy-2026a10004kv?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 2/27/26 | From Prescription to Practice in Respiratory Diseases: Overcoming Barriers to Inhaler Adherence and Compliance | Are you optimizing inhaler choice and technique to achieve better outcomes? Credit available for this activity expires: 2/27/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/prescription-practice-respiratory-diseases-overcoming-2026a100058h?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 2/27/26 | The CLL Consultation: Partnering With Patients for Person-Centred Care | Do you know how person-centred care can help address the challenges faced by chronic lymphocytic leukaemia (CLL) patients? Credit available for this activity expires: 02/26/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/cll-consultation-partnering-patients-person-centred-care-2026a10005ap?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 2/27/26 | Immunotherapy for Non-Muscle-Invasive Bladder Cancer: Expert Takeaways From the Latest Updates | Did you know that combining Bacillus Calmette-Guérin (BCG) with immunotherapy significantly improves outcomes in high-risk bladder cancer? Credit available for this activity expires: 2/24/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/immunotherapy-non-muscle-invasive-bladder-cancer-expert-2026a10005af?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 2/19/26 | Navigating the HER2 Spectrum in Breast Cancer: Evolving Diagnostic Paradigms for Clinical Excellence | Are you up to date on HER2 testing best practices? Join our expert panel and discover the critical updates that guide treatment selection. Credit available for this activity expires: 2/17/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/navigating-her2-spectrum-breast-cancer-evolving-diagnostic-2026a10004ea?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 2/6/26 | 2025 Winter Conference Update: Novel and Emerging Treatment Strategies for Breast Cancer | What do the latest data from the 2025 breast cancer Winter Conference tell us? Credit available for this activity expires: 02/02/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/winter-conference-update-novel-and-emerging-treatment-2026a100030r?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 2/2/26 | A Case-Based Journey From Risk to Results | Known as a "silent" disease because it has few or no symptoms, MASH increases cirrhosis, cancer, and death rates despite being both detectable and treatable. Credit available for this activity expires: 01/30/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/case-based-journey-risk-results-2026a10002fy?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 1/30/26 | HER2-Positive Early Breast Cancer: What the Latest Data Mean for Your Practice | Are you up-to-date on the latest data in HER2-positive early breast cancer? Join our experts as they discuss the data and the clinical implications! Credit available for this activity expires: 01/29/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/her2-positive-early-breast-cancer-what-latest-data-mean-your-2026a10002fg?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 1/20/26 | Balancing ART and Comorbidities in Aging People Living With HIV | How can we optimize ART in people living with HIV while addressing comorbidities and minimizing toxicity? Credit available for this activity expires: 01/15/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/balancing-art-and-comorbidities-aging-people-living-hiv-2026a1000127?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 1/5/26 | The Alarming Carbon Footprint of Respiratory Disease: The Future of Sustainable Inhaler Technology | Low-carbon inhalers: Are you finding the right balance for optimal patient care and planetary health? Credit available for this activity expires: 12/31/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/alarming-carbon-footprint-respiratory-disease-future-2025a1000y0k?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 1/5/26 | Achieving Brain Health in Epilepsy: What Can Clinicians Do? | Are you asking about sleep, activity levels, and mood? Why you should be and what to do next. Credit available for this activity expires: 12/31/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/achieving-brain-health-epilepsy-what-can-clinicians-do-2025a1000y6t?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 12/31/25 | Patient Case Challenge: How Would You Manage This Patient With MASH? | Discover the patients who need timely treatment for metabolic dysfunction–associated steatohepatitis (MASH). How will you find them? And then what will you do? Credit available for this activity expires: [12/30/26] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/patient-case-challenge-how-would-you-manage-this-patient-2025a1000zqo?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 12/24/25 | Navigating the Challenges of IgAN Management: Clinical Implications of Emerging B-Cell Therapies | Alarming in immunoglobulin A nephropathy (IgAN): over 40% present late. Explore latest advancements in management of the most common cause of primary glomerulonephritis worldwide. Credit available for this activity expires: 12/23/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/navigating-challenges-igan-management-clinical-implications-2025a1000w9b?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 12/19/25 | Person-Centered Care in EGFR-Mutated Advanced NSCLC: Optimizing Outcomes and Experiences | How well are you managing patients on EGFR inhibitor therapies in your clinical practice? Credit available for this activity expires: 12/18/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/person-centered-care-egfr-mutated-advanced-nsclc-optimizing-2025a1000xxa?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 12/18/25 | Charting the Course in CLL: A Clinician's Compass for BTK Inhibitor Therapy | Learn from the experts about selecting the right BTK inhibitor therapy for patients with chronic lymphocytic leukaemia (CLL) in UK clinical practice. Credit available for this activity expires: 12/16/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/charting-course-cll-clinicians-compass-btk-inhibitor-therapy-2025a1000yei?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
| 12/12/25 | How Are ADCs Shaping the Future of Early Breast Cancer Care? Latest Insights and Emerging Strategies | Did you know that, while well established in the metastatic setting, second-generation antibody-drug conjugates are now moving into the early setting? Credit available for this activity expires: 12/10/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/how-are-adcs-shaping-future-early-breast-cancer-care-latest-2025a1000yca?ecd=bdc_podcast_libsyn_mscpedu | — | ||||||
Showing 25 of 596
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
5 placements across 5 markets.
Chart Positions
5 placements across 5 markets.